Gideon Capital Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-5,578
| Closed | -$495K | – | 282 |
|
|
2019
Q1 | $495K | Sell |
5,578
-3,585
| -39% | -$318K | 0.18% | 170 |
|
|
2018
Q4 | $780K | Buy |
9,163
+4,124
| +82% | +$351K | 0.32% | 92 |
|
|
2018
Q3 | $489K | Buy |
5,039
+677
| +16% | +$65.7K | 0.23% | 148 |
|
|
2018
Q2 | $411K | Buy |
+4,362
| New | +$411K | 0.21% | 187 |
|
|
2018
Q1 | – | Sell |
-2,862
| Closed | -$255K | – | 351 |
|
|
2017
Q4 | $255K | Sell |
2,862
-1,536
| -35% | -$137K | 0.22% | 200 |
|
|
2017
Q3 | $409K | Buy |
4,398
+2,088
| +90% | +$194K | 0.4% | 72 |
|
|
2017
Q2 | $210K | Sell |
2,310
-1,721
| -43% | -$156K | 0.23% | 223 |
|
|
2017
Q1 | $354K | Sell |
4,031
-1,922
| -32% | -$169K | 0.21% | 191 |
|
|
2016
Q4 | $494K | Buy |
+5,953
| New | +$494K | 0.32% | 92 |
|
|
2014
Q3 | – | Sell |
-11,941
| Closed | -$743K | – | 273 |
|
|
2014
Q2 | $743K | Buy |
+11,941
| New | +$743K | 0.27% | 120 |
|